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Abstract. Marfan syndrome is a pleiotropic connective tissue disease inherited as an 
autosomal dominant trait, mostly caused by mutations in the FBN1 gene, which is located on 
chromosome 15q21.1 and encoding fibrillin 1. We report a case of Marfan syndrome presen-
ting with severe ocular and systemic manifestations, such as cardiac congenital anomalies. 
The patient underwent a multidisciplinary approach and his clinical diagnosis was associated 
with a c.3037G>A mutation in the FBN1 gene. Identification of this genetic alteration should 
instigate a prompt multidisciplinary assessment and monitoring, in order to prevent devasta-
ting consequences such as cardiac and ocular phenotype. Molecular modeling of the mutation 
highlighted the importance of the preservation of the calcium-dependent structure of an epi-
dermal-growth-factor-like domain of fibrillin-1 and consequently the microfibrillar formation 
process. This report aims to highlight the importance of an early clinical and molecular diag-
nosis and once more, the importance of the multidisciplinary approach of this genetic entity.
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Mutación c.3037G>A en el gen FBN1 causa sindrome 
de Marfan con fenotipo atípico severo.
Invest Clin 2017; 58(1): 70 - 78
Palabras clave: síndrome de Marfan; c.3037G>A; FBN1; manifestaciones oculares.
Resumen. El síndrome de Marfan es una enfermedad pleitrópica del tejido conjuntivo 
que exhibe un patrón de herencia autosómico dominante, en su mayoría causado por mutacio-
nes en el gen FBN1, que se encuentra en el cromosoma 15q21.1 y codifica a la fibrilina 1. Se 
presenta un caso de síndrome de Marfan que cursa con manifestación sistémica severa cardíaca 
y principlamente ocular. El paciente presentó una valoración multidisciplinaria y su diagnósti-
co clínico fue asociado con la mutación c.3037G>A en el gen FBN1. La identificación de esta 
alteración genética debe promover una pronta evaluación y supervisión con el fin de evitar las 
desvastadoras consecuencias, tales como el fenotipo cardíaco y ocular. El modelado compara-
tivo de proteínas  resalta la importancia de la conservación de la estructura del dominio de la 
fibrilina-1 dependiente de calcio similar al factor de crecimiento epidérmico y por lo tanto el 
proceso de formación microfibrilar. Este informe tiene como objetivo resaltar la importancia 
de un diagnóstico clínico y molecular temprano y el enfoque multidisciplinariode esta entidad 
genética. 
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INTRODUCTION         
Marfan syndrome (MFS, OMIM #154700) 
is a rare genetic pleiotropic disorder, presen-
ting with skeletal, ocular, skin, and cardiovas-
cular symptoms. First described by the French 
pediatrician Antoine Bernard-Jean Marfan in 
1896, is an inherited connective tissue disease 
mostly transmitted as an autosomal dominant 
trait resulting from mutations in the FBN1gene 
(OMIM #134797). This gene contains 66 exons, 
is located on chromosome 15q21.1 and encodes 
fibrillin, an important protein of the extracellu-
lar matrix, that contributes to the final structu-
re of a microfibril (1, 2). Estimated incidences 
range between 1:5,000 to 10,000 live births and 
no gender or ethnic associations have  been re-
ported (2).
Three international nosologies have been 
proposed for the diagnosis of MFS, the Berlin 
nosology in 1988, was purely based on the cli-
nical phenotype. The Ghent nosology in 1996 
(Ghent-1), which was a revision of the Berlin 
criteria, used the discovered FBN1 mutations as 
a component in the diagnostic criteria, and sub-
sequently, the revised Ghent nosology in 2010 
(Ghent-2), highlighted the FBN1 mutation, aor-
tic dilatation and “ectopia lentis” in the diagnosis 
of this entity (3-5). Moreover, mutations in the 
FBN1 gen can result in classic MFS, neonatal 
MFS, “ectopia lentis”, familial ascending aortic 
aneurysm and isolated skeletal abnormalities. 
These conditions are collectively termed type-1 
fibrillinopathies. There is a remarkable degree 
of clinical variability both intra- and inter-fami-
ly with FBN1 mutations, which has made the 
investigation of the genotype–phenotype corre-
lations difficult (6). However, molecular genetic 
71A c.3037G>A mutation in the FBN1 gene causing Marfan syndrome
Vol. 58(1): 70 - 78, 2017 
clin-6- 1551.indd   76 03/04/2017   09:56:06 a.m.
testing of FBN1 is central to diagnosis, genetic 
counselling and to document a potential geno-
type-phenotype correlation (7). We report case 
of a male patient with a heterozygous missen-
se mutation c.3037G>A in the FBN1 gene with 
MFS presenting severe cardiac and mainly ocu-
lar phenotype.
CLINICAL REPORT
Here we report the case of a 25-year-old Ita-
lian male with MFS, presenting severe cardiac 
and mainly ocular phenotype. From available 
medical records: at birth arthrogryposis and ex-
cessive length were seen, associated with tran-
sient oxygen requirement due to poor respira-
tory adaptation of the newborn, that improved in 
the first two weeks of life. During the first two 
years of life, high stature, and mild motor retar-
dation, characterized by difficult walking were 
suggestive of MFS. Subsequently, several ano-
malies were evidenced: narrow palate, pectus 
excavatum, recurrent hernias, arachnodactyly, 
general marfanoid physical aspect, and joint 
laxity with a high degree of elbow extension, 
besides cardiac and ocular anomalies.
Echocardiography revealed mild dilatation 
of ascending aorta, associated with mild aortic 
regurgitation in the first year of age. Though 
asymptomatic, the diameter of the ascending 
aorta progressed up to 4 cm with clear aneu-
rysm evolution in few years; for this reason, the 
patient underwent elective ascending aorta re-
placement and conservative aortic valve surgery 
at age 5. During subsequent years, aortic valve 
regurgitation recurred and worsened, together 
with mitral valve prolapse and regurgitation. 
The patient was treated with beta-blockers and 
ace-inhibitors for some years, waiting for com-
plete pubertal development. When he was 16 
years old the aortic and mitral  dysfunction had 
become severe, with volume remodeling of the 
left ventricle, left atrium enlargement and se-
vere bivalvular regurgitations. After discussion 
about the surgical options, the patient chose val-
ve replacement with mechanical prosthesis, and 
chronic oral anticoagulants. The surgeon was 
able to repair the mitral valve and substituted 
the aortic valve with a mechanical prosthesis.
Concerning the ocular history the patient 
presented bilateral posterior lens dislocation 
in the first year of life. In the first decade the 
patient underwent lensectomy, vitrectomy and 
scleral buckling in each eye for total retinal de-
tachment. His axial lengths were 33.0 mm right 
and 32.5 mm left. Silicone oil tamponade was 
required due to recurrent retinal detachment. 
The patient subsequently developed in silicone 
oil keratopathy with corneal endothelial failure 
and decompensation in the right eye requiring 
two penetrating keratoplasties, at ages 21 and 
23, respectively. His visual acuities were no per-
ception of light in the right eye and hand move-
ments in the left eye. The refraction was +3.50 
+1.00 at 70° in the right eye and +4.00 +1.00 
at 10° in the left eye. Slit-lamp examination 
was performed at age 25 and demonstrated bi-
lateral aphakia, corneal opacity with peripheral 
neovascularization in the right eye and a trans-
parent cornea in the left eye. The intra-ocular 
pressure was 14 mmHg in each eye as measured 
by Goldmann applanation tonometry. Fundus 
examination showed bilateral persistent retinal 
detachment in each eye (Fig. 1 a,b).
Clinical and radiological dental examination 
at 20 years age revealed dental defects such as 
macrodontia and he had been treated with cu-
rrent recommendations. The patient was not 
affected by mental retardation, he completed 
university studies until graduation, spite of his 
total blindness status.
The DNA extracted from peripheral blood 
and Sanger sequencing, demonstrated a he-
terozygous missense mutation c.3037G>A in 
exon 24 of the FBN1 gene (NM_000138) re-
sulting in a non-conservative substitution of a 
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glycine residue for arginine (p.G1013R). Ho-
mology modeling of fibrillin-1 in the 909-1069 
amino acid region was made with the program 
MODELLER (9v10) (8), using as the template 
the structure of the calcium-bound fragment (re-
sidues 1486-1647) of the same protein (Protein 
Data Bank, PDB, entry 1UZK), according to the 
sequence alignment shown in (Fig. 2).
DISCUSSION
The patient studied here had an atypically 
severe MFS, according Tiecke et al (6), in which 
the clinical peculiarities are the extraordinary 
early manifestations of severe aortic anomalies, 
leading to aneurysm development in the first 
years of life, together with the relatively early, 
but severely evolving ophthalmologic anoma-
lies, in a sporadic case. Based on its clinical 
course and severity, differential diagnoses with 
Loyes Dietz syndrome could be discussed, but 
genetic molecular findings definitely excluded, 
confirming the diagnosis of MFS associated 
with (c.3037G>A; p.G1013R) mutation in the 
FBN1gene. This mutation was previously repor-
ted in three unrelated patients with severe and 
atypically severe manifestations, with neonatal 
presentation (6,7). The mutation affects a highly 
conserved residue in an interdomain linkage re-
gion and was first reported by Nijbroek et al (7), 
in a patient with neonatal presentation. Tiecke et 
al (6), identified this mutation by heteroduplex 
screening in two unrelated patients with severe 
clinical involvement, who were not members of 
their initial screening group. In Table I, is des-
cribed a comparative clinical feature between 
the patients studied with the same mutation.
Among cardiovascular manifestations, mi-
tral valve dysfunction, dilation of the ascending 
aorta and aneurysm are the most frequent. Aor-
tic dilation is present in 35% of patients prior to 
5 years of age and up to 70% of patients prior 
to 20 years of age. Aortic pathology often ne-
cessitates surgical measures, including aortic 
root replacement at an early age (9, 10). These 
conditions were present at an early age in the 
patient studied
The main ocular manifestations in MFS are 
myopia and “ectopia lentis”. The subluxation or 
luxation of the lens is reported in approximately 
45 – 87% (11) of the cases. Börger found “ecto-
pia lentis” to be part of MFS in 1914, and this 
entity is reported to be its most prevalent cause. 
In a ocular study in 87 patients with MFS, the 
“ectopia lentis” was found in 108 eyes (62.1%). 
Moreover, of the 68 phakic eyes with “ectopia 
73A c.3037G>A mutation in the FBN1 gene causing Marfan syndrome
Vol. 58(1): 70 - 78, 2017 
(a) Right eye - corneal opacity with peripheral neovascularization developed after penetrating keratoplasty; 
(b) Left eye, transparent cornea in left eye with deep anterior chamber, aphakia and slight pupil deformation.
Fig.1. 
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lentis”, 43 (63.2%) had subluxation. Myopia 
above 3D occurred in 38.4% of the phakic eyes 
(12). Other ocular findings includes glaucoma 
secondary to aphakia, abnormally flat cornea, 
increased axial length of the globe, hypoplastic 
iris, orciliary muscle responsible for decreased 
miosis, and an increased risk of retinal detach-
ment (11).
Retinal detachment is a serious complication 
of MFS occurring in 5-11% of patients (13). The 
frequency increases to 8 – 38% in the presence 
of “ectopia lentis” (13, 14). Moreover, myopia, 
previous intraocular surgery, and increased axial 
length are associated with a high risk of retinal 
detachment (15). MFS patients are also more 
prone to develop retinal detachment because 
of unstable subluxated or dislocated lens which 
exerts traction on the vitreous base leading to 
74 Callea y col.
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Homology model of Fibrillin-1. (a) Shown is the homology model of Fibrillin-1 in the amino acid inter-
val 909-1069 (fully encompassing a group of consecutive EGF-like/TGF-beta binding /EGF-like domains). 
The G1013R site is highlighted with meshes, and functional residues involved in calcium binding within the 
EGF-like domain located in the C-terminal direction are shown (the enlarged view is shown in the inset). The 
Ca2+ ion is placed in the model according to the position observed in the template structure (PDB structure 
1UZK).
(b) Pairwise sequence alignment (clustal format) of Fibrillin-1 and the template used for homology modeling. 
The position of glycine 1013 (site of mutation) is indicated by the red arrow. Residues involved in the binding 
of the Ca2+ ion and cysteine residues contributing to patterns of disulfides, as inferred from the crystal struc-
ture, are respectively highlighted in azure and yellow colors in both sequences.
Fig.2. 
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small tears or holes in the periphery of the reti-
na. Scleral buckling is recommended as a first 
surgical procedure (13), if the crystalline lens 
is normally placed and vitrectomy and internal 
tamponade is required in the presence of failed 
scleral buckling, proliferative vitreoretinopa-
thy, a posteriorly dislocated lens, a subluxated 
or cataracts lens, not allowing an adequate eva-
luation of the fundus periphery and giant retinal 
tears (16,17). In the case mentioned here, bila-
teral spontaneous complete posterior lens dis-
location developed in early childhood, bilateral 
total rhegmatogenous retinal detachment persis-
ted in spite of repeated vitrectomies and internal 
tamponade. Corneal decompensation followed 
silicone oil keratopathy and two penetrating 
keratoplasties were performed. Prompt and ag-
gressive treatment of ocular complication failed 
to prevent more severe visual loss and was una-
ble to improve the quality of the patient’s life. 
The FBN1gene encodes for fibrillin-1, 
which is a 350 kDa glycoprotein member of 
the fibrillin family, that are the major compo-
nents of microfibrils in the extracellular matrix 
of elastic and non-elastic tissues. These proteins 
have a modular structure composed of several 
epidermal-growth-factor-like (EGF) domains 
(both the type with calcium-binding ability and 
the type unable to bind calcium are present) 
and a number of transforming growth factor 
(TGF)-beta binding domains, which contribute 
to the structure of 10-12 nm thick microfibrils 
in the extracellular matrix in a calcium depen-
dent manner (18). The (c.3037G>A; p.G1013R) 
mutation falls in a peptide linker between a 
TGF-beta binding domain and an EGF-like do-
main, and to investigate the possible effects of 
this mutation on the protein we built the structu-
ral model of the 909-1069 amino acid region of 
fibrillin-1 (encompassing a group of three con-
secutive EGF-like/TGF-beta binding/EGF-like 
domains), based on the homology (44% ami-
no acid identity) shared with the structurally 
characterized amino acid region 1486-1647 of 
the same protein. These two regions of fibri-
llin-1 also share same domain architecture, and 
this allowed modeling the inter-domain linker 
hosting the site of the p.G1013R mutation in 
the context of its interactions with nearby do-
mains. In fact, as shown in (Fig. 2), the glycine 
1013-containing linker is structured and pac-
ked against the calcium-bound structure of the 
EGF-like domain adjacent on the C-terminal 
side, and in particular glycine 1013 contributes 
to a turn and is proximal to the calcium-binding 
residues of this domain. The replacement of the 
neutral and tiny glycine 1013 residue with the 
much bulkier and positively charged arginine 
in the p.G1013R is expected to produce both 
structural and electrostatic perturbations, which 
are expected to impair the calcium-depending 
structure of an EGF-like domain of fibrillin-1 
and likely to interfere with the process of micro-
fibril formation.
In conclusion, the c.3037G>A mutation in 
FBN1 has been previously reported as pathoge-
nic, resulting in either severe or atypically se-
vere or neonatal forms of MFS (6,7). The case 
reported herein highlights severe cardiac pro-
blems encountered and the devastating ocular 
phenotype associated with this specific FBN1 
mutation. Identification of this mutation should 
instigate a prompt cardiac and ophthalmological 
assessment and monitoring, in order to intervene 
with ophthalmic care prior to severe ophthalmic 
consequences. Molecular modelling identified 
that the glycine residue at position 1013 is cru-
cial to preserve the calcium-dependent structure 
of an EFG-like domain of fibrillin-1 and conse-
quently the microfibrillar formation process.
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